Company type | Public |
---|---|
BSE: 539523 NSE: ALKEM | |
Industry | Pharmaceuticals |
Founded | 1973 |
Founder | Samprada Singh [1] |
Headquarters | , India |
Products | Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health |
Revenue | ₹10,634 crore (US$1.3 billion) (2022) [2] |
₹2,052 crore (US$250 million) (2022) [2] | |
₹1,645 crore (US$200 million) (2022) [2] | |
Total assets | ₹14,069 crore (US$1.7 billion) (2022) [2] |
Total equity | ₹8,637 crore (US$1.0 billion) (2022) [2] |
Owner | Sandeep Singh (Managing Director & Executive Director) |
Number of employees | 15,357 (2021) [2] |
Subsidiaries | Galpha Laboratories |
Website | www |
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India and globally.
Alkem set up its research and development facility for ANDA development at Taloja in 2003. [3] In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India. [4] In 2014 Clavam another drug from Alkem crossed 2,000 million mark in terms of domestic sales in India.
In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009. [3] Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved.
Alkem has 21 manufacturing facilities: 19 in India and 2 in the US. [5] These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014, Alkem acquired the "Clindac-A" brand in India from Galderma S.A. In 2015, Alkem acquired a formulation manufacturing facility in the US. [6]
Samprada Singh was the founder and chairman emeritus of the company, he led and shaped Alkem what it is today, he had a B.Com. degree from Patna University. He was the 42nd richest person in India and a billionaire. [7] His brother, Basudeo Narayan Singh, [8] was also the co-founder of the company. Samprada Singh died on 27 July 2019 at the age of 94 years after a brief illness in Mumbai. [9]
As per Forbes list of India’s 100 richest tycoons, dated OCTOBER 09, 2024, Singh family is ranked 41st with a net worth of $7.1 Billion. [10]
Position | Name |
---|---|
Founder Chairman Emeritus | Mr. Samprada Singh |
Executive Chairman | Mr. Basudeo Narayan Singh |
Joint Managing Director | Ms. Dhananjay Kumar Singh |
Joint Managing Director | Mr. Sandeep Singh |
Independent Director | Dr. Dheeraj Sharma |
Independent Director | Mr. A.K. Purwar |
Independent Director | Mr. N. K. Aneja |
Independent Director | Mr. R. L. Shenoy |
Independent Director | Ms. Sangeeta Singh |
Independent Director | Ms. Sudha Ravi [11] |
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals.
Samprada Singh was an Indian businessman, who was the founder and chairman of Alkem Laboratories, which develops, manufactures and markets pharmaceutical formulations and nutraceuticals in India. It has operations in Europe, Africa, the Asia Pacific, South America, the United States and India.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe.
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.
Rubicon Research is an IP led, specialty pharmaceutical company located in Mumbai, India. Its formulation development is across multiple dosage forms, oral solids, oral liquids, nasal, ophthalmic, topical, injectable, fixed dose combinations, and drug device combinations. In 2019 the company received USD 100 million in growth capital investment from General Atlantic, a growth equity firm.
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals.
Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India. Its market presence is in more than 100+ countries.
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate.
Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates, finished formulations, food supplements, biotechnology products and pharmaceutical machinery.
ACG is a multinational pharmaceutical company with headquarters in Mumbai, India. The company has presence in over 100 countries on six continents. ACG is the world’s largest integrated supplier of solid dosage products and services. ACG provides empty hard pharmaceutical capsules, encapsulation machinery, tablet coating systems, tablet compression systems, fluid bed equipment, tablet tooling, and performance enhancers along with online and inline analytical and inspection systems. The company also provides blister packing, high barrier packaging films, carton packing machines, camera inspection systems, candy-wrapping machines, and end-of-line case packers. ACG has about 4,500 employees.
Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.